![News - CHMP Recommends Additional Authorisation Modification of Comirnaty ( BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut News - CHMP Recommends Additional Authorisation Modification of Comirnaty ( BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut](https://www.pei.de/SharedDocs/Bilder/EN/newsroom-en/hp-news-pm/omicron-ba5-chmp.jpg?__blob=thumbnail&v=6)
News - CHMP Recommends Additional Authorisation Modification of Comirnaty ( BioNTech/Pfizer) As a Bivalent Vaccine Adapted to Omicron BA.4/BA.5 for Booster Vaccinations - Paul-Ehrlich-Institut
![Newly developed Pfizer-BioNTech bivalent COVID-19 booster shots to be made available in the Kingdom of Bahrain | The official website for the latest health developments, Kingdom of Bahrain Newly developed Pfizer-BioNTech bivalent COVID-19 booster shots to be made available in the Kingdom of Bahrain | The official website for the latest health developments, Kingdom of Bahrain](https://www.moh.gov.bh/Content/Upload/Image/638053206911107061-350C64EF-10FE-4D4A-BB6D-6C737713EDBF.jpeg)
Newly developed Pfizer-BioNTech bivalent COVID-19 booster shots to be made available in the Kingdom of Bahrain | The official website for the latest health developments, Kingdom of Bahrain
![Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant - ABC News Pfizer, BioNTech say bivalent COVID-19 booster shot performs better against BA.5 omicron subvariant - ABC News](https://s.abcnews.com/images/Health/pfizer-biontech-bivalent-booster-file-rt-221_hpMain_20221104-050026_16x9_1600.jpg)